Clariant AG
Clariant AG (CLZNF) Financial Performance & Income Statement Overview
Review Clariant AG (CLZNF) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Clariant AG (CLZNF) Income Statement & Financial Overview
Explore comprehensive income reports for Clariant AG CLZNF, broken down by year and quarter.
| Metric | Q4 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $2.08B | $2.07B | $1.03B | $2.09B |
| Cost of Revenue | $1.43B | $1.44B | $717.50M | $1.51B |
| Gross Profit | $654.00M | $635.00M | $317.50M | $584.00M |
| Gross Profit Ratio | $0.31 | $0.31 | $0.31 | $0.28 |
| R&D Expenses | $67.00M | $61.00M | $30.50M | $68.00M |
| SG&A Expenses | $372.00M | $366.00M | $183.00M | $332.00M |
| Operating Expenses | $439.00M | $406.00M | $203.00M | $400.00M |
| Total Costs & Expenses | -$1.87B | $1.84B | $920.50M | $1.91B |
| Interest Income | $11.00M | $36.00M | $2.00M | $31.00M |
| Interest Expense | $77.00M | $44.00M | $0.00 | $63.00M |
| Depreciation & Amortization | $128.00M | $97.00M | $48.50M | $116.00M |
| EBITDA | $320.00M | $301.00M | $150.50M | $158.00M |
| EBITDA Ratio | $0.15 | $0.15 | $0.15 | $0.14 |
| Operating Income | $215.00M | $229.00M | $102.00M | $184.00M |
| Operating Income Ratio | $0.10 | $0.11 | $0.10 | $0.09 |
| Other Income/Expenses (Net) | -$100.00M | -$4.00M | $10.50M | -$176.00M |
| Income Before Tax | $115.00M | $225.00M | $112.50M | $8.00M |
| Income Before Tax Ratio | $0.06 | $0.11 | $0.11 | $0.004 |
| Income Tax Expense | $41.00M | $49.00M | $24.50M | $45.00M |
| Net Income | $87.00M | $157.00M | $78.50M | -$75.00M |
| Net Income Ratio | $0.04 | $0.08 | $0.08 | -$0.04 |
| EPS | $0.27 | $0.48 | $0.24 | -$0.23 |
| Diluted EPS | $0.26 | $0.48 | $0.24 | -$0.23 |
| Weighted Avg Shares Outstanding | $328.29M | $328.98M | $328.98M | $328.85M |
| Weighted Avg Shares Outstanding (Diluted) | $330.33M | $330.33M | $330.33M | $328.85M |
Over the past four quarters, Clariant AG demonstrated steady revenue growth, increasing from $2.09B in Q4 2023 to $2.08B in Q4 2024. Operating income reached $215.00M in Q4 2024, maintaining a consistent 10% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $320.00M, reflecting operational efficiency. Net income dropped to $87.00M, with EPS at $0.27. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan